{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:56:50Z","timestamp":1790056610223,"version":"4.0.1"},"reference-count":66,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_pp-2018-0124_s_006_w2aab3b7b3b1b6b1aab1c16b1Aa\">\n                    <jats:title id=\"d1045279e5567_w2aab3b7b3b1b6b1aab1c16b1aAa\">Background<\/jats:title>\n                    <jats:p>The aim of this review was to analyze preclinical studies and clinical trials evaluating photodynamic therapy (PDT), and photothermal therapy (PTT) in peritoneal metastasis (PM) treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2018-0124_s_007_w2aab3b7b3b1b6b1aab1c16b2Aa\">\n                    <jats:title id=\"d1045279e5575_w2aab3b7b3b1b6b1aab1c16b2aAa\">Content<\/jats:title>\n                    <jats:p>Systematic review according PRISMA guidelines. Electronic searches using PubMed and Clinical Trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2018-0124_s_008_w2aab3b7b3b1b6b1aab1c16b3Aa\">\n                    <jats:title id=\"d1045279e5583_w2aab3b7b3b1b6b1aab1c16b3aAa\">Summary<\/jats:title>\n                    <jats:p>A total of 19 preclinical studies analyzing PDT in PM treatment were included. Each new generations of photosensitizers (PS) permitted to improve tumoral targeting. Phase III preclinical studies showed an important tumoral biodistribution (ratio 9.6 vs normal tissue) and significant survival advantage (35.5 vs 52.5 days for cytoreductive surgery vs cytoreductive surgery+PDT, p&lt;0.005). Height clinical trials showed important side effects (capillary leak syndrome and bowel perforation), mainly explained by low tumor-selectivity of the PS used (first generation mainly).<\/jats:p>\n                    <jats:p>Peritoneal mesothelioma apparition with carbon nanotubes first limited the development of PTT. But gold nanoparticles, with a good tolerance, permitted a limitation of tumoral growth (reduction of bioluminescence to 37\u2006% 20 days after PTT), and survival benefit (35, 32, and 26 days for PTT with cisplatine, PTT alone and laser alone, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2018-0124_s_009_w2aab3b7b3b1b6b1aab1c16b4Aa\">\n                    <jats:title id=\"d1045279e5594_w2aab3b7b3b1b6b1aab1c16b4aAa\">Outlook<\/jats:title>\n                    <jats:p>Recent improvement in tumor-selectivity and light delivery systems is promising but further development would be necessary before PDT and PTT routinely applied for peritoneal carcinomatosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/pp-2018-0124","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T04:02:37Z","timestamp":1545105757000},"source":"Crossref","is-referenced-by-count":63,"title":["Photodynamic therapy and photothermal therapy for the treatment of peritoneal metastasis: a systematic review"],"prefix":"10.1515","volume":"3","author":[{"given":"Amandine","family":"Pinto","sequence":"first","affiliation":[{"name":"Paris Diderot University, Sorbonne Paris Cit\u00e9 , CART, INSERM U965, Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Pocard","sequence":"additional","affiliation":[{"name":"Paris Diderot University, Sorbonne Paris Cit\u00e9 , CART, INSERM U965, Paris , France"},{"name":"Surgical Oncologic & Digestive Unit, Lariboisi\u00e8re Hospital , AP-HP, 2 rue Ambroise Par\u00e9, 75475 Paris Cedex 10 , France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2018,12,18]]},"reference":[{"key":"2025120909201197956_j_pp-2018-0124_ref_001_w2aab3b7b3b1b6b1ab1b7b1Aa","doi-asserted-by":"crossref","unstructured":"Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737\u201343.10.1200\/JCO.2003.04.18714551293","DOI":"10.1200\/JCO.2003.04.187"},{"key":"2025120909201197956_j_pp-2018-0124_ref_002_w2aab3b7b3b1b6b1ab1b7b2Aa","doi-asserted-by":"crossref","unstructured":"Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27:681\u20135.1910372810.1200\/JCO.2008.19.7160","DOI":"10.1200\/JCO.2008.19.7160"},{"key":"2025120909201197956_j_pp-2018-0124_ref_003_w2aab3b7b3b1b6b1ab1b7b3Aa","doi-asserted-by":"crossref","unstructured":"Glehen O, Osinsky D, Cotte E, Kwiatkowski F, Freyer G, Isaac S, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol. 2003;10:863\u20139.10.1245\/ASO.2003.01.01814527903","DOI":"10.1245\/ASO.2003.01.018"},{"key":"2025120909201197956_j_pp-2018-0124_ref_004_w2aab3b7b3b1b6b1ab1b7b4Aa","doi-asserted-by":"crossref","unstructured":"Simkens GA, van Oudheusden TR, Braam HJ, Luyer MD, Wieyer MJ, van Ranshorst B, et al. Treatment related mortality after cytoreductive surgery and HIPEC in patients with colorectal peritoneal carcinomatosis is underestimated by conventional parameters. Ann Surg Oncol. 2016;23:99\u2013105.10.1245\/s10434-015-4699-526148758","DOI":"10.1245\/s10434-015-4699-5"},{"key":"2025120909201197956_j_pp-2018-0124_ref_005_w2aab3b7b3b1b6b1ab1b7b5Aa","doi-asserted-by":"crossref","unstructured":"Mirnezami R, Moran BJ, Harvey K, Cecil T, Chandrakumaran K, Carr N, et al. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases. World J Gastroenterol. 2014;20:14018\u201332.10.3748\/wjg.v20.i38.1401825320542","DOI":"10.3748\/wjg.v20.i38.14018"},{"key":"2025120909201197956_j_pp-2018-0124_ref_006_w2aab3b7b3b1b6b1ab1b7b6Aa","doi-asserted-by":"crossref","unstructured":"Pinto A, Eveno C, Pocard M. Update on clinical trials in colorectal cancer peritoneal metastasis. Int J Hyperthermia. 2017;33:543\u20137.2814228810.1080\/02656736.2017.1289565","DOI":"10.1080\/02656736.2017.1289565"},{"key":"2025120909201197956_j_pp-2018-0124_ref_007_w2aab3b7b3b1b6b1ab1b7b7Aa","doi-asserted-by":"crossref","unstructured":"Diamond I, Granelli SG, McDonagh AF, Nielsen S, Wilson CB, Jaenicke R. Photodynamic therapy of malignant tumours. Lancet. 1972;2:1175\u20137.4117595","DOI":"10.1016\/S0140-6736(72)92596-2"},{"key":"2025120909201197956_j_pp-2018-0124_ref_008_w2aab3b7b3b1b6b1ab1b7b8Aa","doi-asserted-by":"crossref","unstructured":"Dougherty TJ, Gomer CJ, Henderson Bw, Jori G, Kessel D, Korbelik M, et al. J Natl Cancer Inst. 1998;90:889\u2013905.963713810.1093\/jnci\/90.12.889","DOI":"10.1093\/jnci\/90.12.889"},{"key":"2025120909201197956_j_pp-2018-0124_ref_009_w2aab3b7b3b1b6b1ab1b7b9Aa","unstructured":"Aza\u00efs H, Mordon S, Collinet P. Intraperitoneal photodynamic therapy for peritoneal metastasis of epithelial ovarian cancer. Limits and future prospects. Gynecol Obstet Fertil Senol. 2017;45:249\u201356.28373041"},{"key":"2025120909201197956_j_pp-2018-0124_ref_010_w2aab3b7b3b1b6b1ab1b7c10Aa","doi-asserted-by":"crossref","unstructured":"Cengel KA, Glatstein E, Hahn SM. Intraperitoneal photodynamic therapy. Cancer Treat Res. 2007;134:493\u2013514.17633077","DOI":"10.1007\/978-0-387-48993-3_34"},{"key":"2025120909201197956_j_pp-2018-0124_ref_011_w2aab3b7b3b1b6b1ab1b7c11Aa","doi-asserted-by":"crossref","unstructured":"Kelly JF, Snell ME, Berenbaum MC. Photodynamic destruction of human bladder carcinoma. Br J Cancer. 1975;31:237\u201344.116447010.1038\/bjc.1975.30","DOI":"10.1038\/bjc.1975.30"},{"key":"2025120909201197956_j_pp-2018-0124_ref_012_w2aab3b7b3b1b6b1ab1b7c12Aa","doi-asserted-by":"crossref","unstructured":"Laksmipathi T, Gould P, Johnson BE, Mackenzie LA, Frain-Bell W. Proceedings: photochemotherapy. A study of its efficacy in fifty patients suffering from psoriasis and other dermatoses. Br J Dermatol. 1976;95:20\u20131.1276046","DOI":"10.1111\/j.1365-2133.1976.tb07892.x"},{"key":"2025120909201197956_j_pp-2018-0124_ref_013_w2aab3b7b3b1b6b1ab1b7c13Aa","doi-asserted-by":"crossref","unstructured":"St\u00fcttgen G. The risk of photochemotherapy. Int J Dermatol. 1982;21:198\u2013202.704741710.1111\/j.1365-4362.1982.tb02071.x","DOI":"10.1111\/j.1365-4362.1982.tb02071.x"},{"key":"2025120909201197956_j_pp-2018-0124_ref_014_w2aab3b7b3b1b6b1ab1b7c14Aa","doi-asserted-by":"crossref","unstructured":"Cortese DA, Kinsey JH. Hematoporphyrin-derivative phototherapy for local treatment of cancer of the tracheobronchial tree. Ann Otol Rhinol Laryngol. 1982;91:652\u20135.10.1177\/0003489482091006286216847","DOI":"10.1177\/000348948209100628"},{"key":"2025120909201197956_j_pp-2018-0124_ref_015_w2aab3b7b3b1b6b1ab1b7c15Aa","doi-asserted-by":"crossref","unstructured":"Kato H, Konaka C, Ono J, Matsushima Y, Nishimiya K, Lay J, et al. Effectiveness of HPD and radiation therapy in lung cancer. Adv Exp Med Biol. 1983;160:23\u201339.10.1007\/978-1-4684-4406-3_46301227","DOI":"10.1007\/978-1-4684-4406-3_4"},{"key":"2025120909201197956_j_pp-2018-0124_ref_016_w2aab3b7b3b1b6b1ab1b7c16Aa","doi-asserted-by":"crossref","unstructured":"McCaughan JS, Jr, Hicks W, Laufman L, May E, Roach R. Palliation of esophageal malignancy with photoradiation therapy. Cancer. 1984;54:2905\u201310.620899410.1002\/1097-0142(19841215)54:12<2905::AID-CNCR2820541215>3.0.CO;2-N","DOI":"10.1002\/1097-0142(19841215)54:12<2905::AID-CNCR2820541215>3.0.CO;2-N"},{"key":"2025120909201197956_j_pp-2018-0124_ref_017_w2aab3b7b3b1b6b1ab1b7c17Aa","unstructured":"Tochner Z, Mitchell JB, Harrington FS, Smith P, Russo DT, Russo A. Treatment of murine intraperitoneal ovarian ascetic tumor with hematoporphyrin derivative and laser light. Cancer Res. 1985;45:2983\u20137."},{"key":"2025120909201197956_j_pp-2018-0124_ref_018_w2aab3b7b3b1b6b1ab1b7c18Aa","doi-asserted-by":"crossref","unstructured":"De Smet L, Ceelen W, Remon JP, Vervaet C. Optimization of drug delivery systems for intraperitoneal therapy to extend the residence time of the chemotherapeutic agent. Scientific World J. 2013;25:720858.","DOI":"10.1155\/2013\/720858"},{"key":"2025120909201197956_j_pp-2018-0124_ref_019_w2aab3b7b3b1b6b1ab1b7c19Aa","doi-asserted-by":"crossref","unstructured":"Kohane DS, Tse JY, Yeo Y, Padera R, Shubina M, Langer R. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum. J Biomed Mater Res A. 2006;77:351\u20136116425240","DOI":"10.1002\/jbm.a.30654"},{"key":"2025120909201197956_j_pp-2018-0124_ref_020_w2aab3b7b3b1b6b1ab1b7c20Aa","doi-asserted-by":"crossref","unstructured":"Bennis S, Chapey C, Couvreur P, Robert J. Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture. European Journal of Cancer A. 1994;30:89\u201393.10.1016\/S0959-8049(05)80025-5","DOI":"10.1016\/S0959-8049(05)80025-5"},{"key":"2025120909201197956_j_pp-2018-0124_ref_021_w2aab3b7b3b1b6b1ab1b7c21Aa","doi-asserted-by":"crossref","unstructured":"Cho KJ, Wang X, Nie SM, Chen Z, Dm S. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancern Res. 2008;14:1310\u20136.10.1158\/1078-0432.CCR-07-1441","DOI":"10.1158\/1078-0432.CCR-07-1441"},{"key":"2025120909201197956_j_pp-2018-0124_ref_022_w2aab3b7b3b1b6b1ab1b7c22Aa","doi-asserted-by":"crossref","unstructured":"Sadava D, Coleman A, Kane SE. Liposomal daunorubicin overcomes drug resistance in human breast, ovarian and lung carcinoma cells. J Liposome Res. 2002;12:301\u20139.10.1081\/LPR-12001619612519627","DOI":"10.1081\/LPR-120016196"},{"key":"2025120909201197956_j_pp-2018-0124_ref_023_w2aab3b7b3b1b6b1ab1b7c23Aa","doi-asserted-by":"crossref","unstructured":"Chatterjee DK, Diagaradjane P, Krishnan S. Nanoparticle-mediated hyperthermia in cancer therapy. Ther Deliv. 2011;8:1001\u201314.","DOI":"10.4155\/tde.11.72"},{"key":"2025120909201197956_j_pp-2018-0124_ref_024_w2aab3b7b3b1b6b1ab1b7c24Aa","doi-asserted-by":"crossref","unstructured":"Kennedy LC, Bickford LR, Lewinski NA, Coughlin AJ, Hu Y, Day ES, et al. A new area for cancer treatment: gold-nanoparticles-mediated thermal therapies. Small. 2011;7:169\u201383.10.1002\/smll.201000134","DOI":"10.1002\/smll.201000134"},{"key":"2025120909201197956_j_pp-2018-0124_ref_025_w2aab3b7b3b1b6b1ab1b7c25Aa","doi-asserted-by":"crossref","unstructured":"Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc. 2006;128:2115\u201320.1646411410.1021\/ja057254a","DOI":"10.1021\/ja057254a"},{"key":"2025120909201197956_j_pp-2018-0124_ref_026_w2aab3b7b3b1b6b1ab1b7c26Aa","doi-asserted-by":"crossref","unstructured":"Dickerson EB, Dreaden EC, Huang X, El-Sayed IH, Chu H, Pushpanketh S, et al. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett. 2008;269:57\u201366.10.1016\/j.canlet.2008.04.02618541363","DOI":"10.1016\/j.canlet.2008.04.026"},{"key":"2025120909201197956_j_pp-2018-0124_ref_027_w2aab3b7b3b1b6b1ab1b7c27Aa","doi-asserted-by":"crossref","unstructured":"Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA. 2003;100:13549\u201354.10.1073\/pnas.2232479100","DOI":"10.1073\/pnas.2232479100"},{"key":"2025120909201197956_j_pp-2018-0124_ref_028_w2aab3b7b3b1b6b1ab1b7c28Aa","doi-asserted-by":"crossref","unstructured":"Riley RS, Day ES. Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017;9:4. (epub).","DOI":"10.1002\/wnan.1449"},{"key":"2025120909201197956_j_pp-2018-0124_ref_029_w2aab3b7b3b1b6b1ab1b7c29Aa","doi-asserted-by":"crossref","unstructured":"Loo C, Lin A, Hirsch L, Lee MH, Barton J, Halas N, et al. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat. 2004;3:33\u201340.10.1177\/15330346040030010414750891","DOI":"10.1177\/153303460400300104"},{"key":"2025120909201197956_j_pp-2018-0124_ref_030_w2aab3b7b3b1b6b1ab1b7c30Aa","doi-asserted-by":"crossref","unstructured":"O\u2019Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 2004;209:171\u20136.10.1016\/j.canlet.2004.02.00415159019","DOI":"10.1016\/S0304-3835(04)00144-2"},{"key":"2025120909201197956_j_pp-2018-0124_ref_031_w2aab3b7b3b1b6b1ab1b7c31Aa","doi-asserted-by":"crossref","unstructured":"Paciotti GF, Myer L, Weinreich D, Goia D, Pavel N, McLaughlin RE, et al. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 2004;11:169\u201383.10.1080\/1071754049043389515204636","DOI":"10.1080\/10717540490433895"},{"key":"2025120909201197956_j_pp-2018-0124_ref_032_w2aab3b7b3b1b6b1ab1b7c32Aa","doi-asserted-by":"crossref","unstructured":"Tochner Z, Mitchell JB, Hoekstra HJ, Smith P, DeLuca AM, Barnes M, et al. Photodynamic therapy of the canine peritoneum: normal tissue response to[] intraperitoneal and intravenous photofrin followed by 630 nm light. Lasers Surg Med. 1991;11:158\u201364.182785410.1002\/lsm.1900110210","DOI":"10.1002\/lsm.1900110210"},{"key":"2025120909201197956_j_pp-2018-0124_ref_033_w2aab3b7b3b1b6b1ab1b7c33Aa","doi-asserted-by":"crossref","unstructured":"Perry RR, Smith PD, Evans S, Pass HI. Intravenous vs intraperitoneal sensitizer: implications for intraperitoneal intraperitoneal photodynamic therapy. Photochem Photobiol. 1991;53:335\u201340.182953110.1111\/j.1751-1097.1991.tb03637.x","DOI":"10.1111\/j.1751-1097.1991.tb03637.x"},{"key":"2025120909201197956_j_pp-2018-0124_ref_034_w2aab3b7b3b1b6b1ab1b7c34Aa","unstructured":"Griffin GM, Zhu T, Solonenko M, Del Piero F, Kapakin A, Busch TM, et al. Preclinical evaluation of motexafin lutetium-mediated intraperitoneal photodynamic therapy in a canine model. Clin Cancer Res. 2001;7:374\u201381."},{"key":"2025120909201197956_j_pp-2018-0124_ref_035_w2aab3b7b3b1b6b1ab1b7c35Aa","doi-asserted-by":"crossref","unstructured":"Morlet L, Vonarx-Coinsmann V, Lenz P, Foultier MT, de Brito LX, Stewart C, et al. Correlation between meta(tetrahydroxyphenyl)chlorin (m-THPC) biodistribution and photodynamic effects in mice. J Photochem Photobiol B. 1995;28:25\u201332.779100310.1016\/1011-1344(94)07090-B","DOI":"10.1016\/1011-1344(94)07090-B"},{"key":"2025120909201197956_j_pp-2018-0124_ref_036_w2aab3b7b3b1b6b1ab1b7c36Aa","doi-asserted-by":"crossref","unstructured":"Veenhuizen RB, Ruevekamp MC, Oppelaar H, Helmerhorst TJ, Kenemans P, Stewart FA. Foscan-mediated photodynamic therapy for a peritoneal cancer model: drug distribution and efficacy studies. Int J Cancer. 1997;73:230\u20135.933544810.1002\/(SICI)1097-0215(19971009)73:2<230::AID-IJC12>3.0.CO;2-J","DOI":"10.1002\/(SICI)1097-0215(19971009)73:2<230::AID-IJC12>3.0.CO;2-J"},{"key":"2025120909201197956_j_pp-2018-0124_ref_037_w2aab3b7b3b1b6b1ab1b7c37Aa","doi-asserted-by":"crossref","unstructured":"Ascencio M, Estevez JP, Delemer M, Farine MO, Collinet P, Mordon S. Comparison of continuous and fractioned illumination during hexaminolaevulinate photodynamic therapy. Photodiagnosis Photodyn Ther. 2008;5:210\u20136.10.1016\/j.pdpdt.2008.09.004","DOI":"10.1016\/j.pdpdt.2008.09.004"},{"key":"2025120909201197956_j_pp-2018-0124_ref_038_w2aab3b7b3b1b6b1ab1b7c38Aa","doi-asserted-by":"crossref","unstructured":"Ascencio M, Collinet P, Farine MO, Mordon S. Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of ratovarian cancer following hexaminolevulinate photodynamic therapy. Lasers Surg Med. 2008;40:332\u201341.1856377710.1002\/lsm.20629","DOI":"10.1002\/lsm.20629"},{"key":"2025120909201197956_j_pp-2018-0124_ref_039_w2aab3b7b3b1b6b1ab1b7c39Aa","doi-asserted-by":"crossref","unstructured":"Estevez JP, Ascencio M, Colin P, Farine MO, Collinet P, Mordon S. Continuous or fractionated photodynamic therapy? Comparison of three PDT schemes for ovarian peritoneal micrometastasis treatment in a rat model. Photodiagnosis Photodyn Ther. 2010;7:251\u20137.10.1016\/j.pdpdt.2010.07.007","DOI":"10.1016\/j.pdpdt.2010.07.007"},{"key":"2025120909201197956_j_pp-2018-0124_ref_040_w2aab3b7b3b1b6b1ab1b7c40Aa","doi-asserted-by":"crossref","unstructured":"Song K, Kong B, Li L, Yang Q, Wei Y, Qu X. Intraperitoneal photodynamic therapy for an ovarian cancer ascite model in Fischer 344 rat using hematoporphyrin monomethyl ether. Cancer Sci. 2007;98:1959\u201364.10.1111\/j.1349-7006.2007.00628.x17900310","DOI":"10.1111\/j.1349-7006.2007.00628.x"},{"key":"2025120909201197956_j_pp-2018-0124_ref_041_w2aab3b7b3b1b6b1ab1b7c41Aa","doi-asserted-by":"crossref","unstructured":"Raue W, Kilian M, Braumann C, Atanassow V, Makareinis A, Caldenas S, et al. Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model. Int J Colorectal Dis. 2010;25:245\u201350.10.1007\/s00384-009-0819-7","DOI":"10.1007\/s00384-009-0819-7"},{"key":"2025120909201197956_j_pp-2018-0124_ref_042_w2aab3b7b3b1b6b1ab1b7c42Aa","doi-asserted-by":"crossref","unstructured":"Mroz P, Xia Y, Asanuma D, Konopko A, Zhiyentayev T, Huang YY, et al. Intraperitoneal photodynamic therapy mediated by a fullerene in a mouse model of abdominal dissemination of colon adenocarcinoma. Nanomedicine. 2011;7:965\u201374.10.1016\/j.nano.2011.04.007","DOI":"10.1016\/j.nano.2011.04.007"},{"key":"2025120909201197956_j_pp-2018-0124_ref_043_w2aab3b7b3b1b6b1ab1b7c43Aa","doi-asserted-by":"crossref","unstructured":"Guyon L, Farine MO, Lesage JC, Gevaert AM, Simonin S, Schmitt C, et al. Photodynamic therapy of ovarian cancer peritoneal metastasis with hexaminolevulinate: atoxicity study. Photodiagnosis Photodyn Ther. 2014;11:265\u201374.10.1016\/j.pdpdt.2014.04.006","DOI":"10.1016\/j.pdpdt.2014.04.006"},{"key":"2025120909201197956_j_pp-2018-0124_ref_044_w2aab3b7b3b1b6b1ab1b7c44Aa","unstructured":"Aza\u00efs H, Frochot C, Grabarz A, Khodja Bach S, Colombeau L, Delhem N, et al. Specific folic-acid targeted photosensitizer. The first step toward intraperitoneal photodynamic therapy for epithelial ovarian cancer. Gynecol Obstet Fertil Senol. 2017;45:190\u20136.28359805"},{"key":"2025120909201197956_j_pp-2018-0124_ref_045_w2aab3b7b3b1b6b1ab1b7c45Aa","doi-asserted-by":"crossref","unstructured":"Aza\u00efs H, Schmitt C, Tardivel M, Kerdraon O, Stallivieri A, Frochot C, et al. Assessment of the specificity of a new folate-targeted photosensitizer for peritoneal metastasis of epithelial ovarian cancer to enable intraperitoneal photodynamic therapy. A Preclinical Study. Photodiagnosis Photodyn Ther. 2016;13:130\u20138.10.1016\/j.pdpdt.2015.07.005","DOI":"10.1016\/j.pdpdt.2015.07.005"},{"key":"2025120909201197956_j_pp-2018-0124_ref_046_w2aab3b7b3b1b6b1ab1b7c46Aa","doi-asserted-by":"crossref","unstructured":"Yokoyama Y, Shigeto T, Miura R, Kobayashi A, Mizunuma M, Yamauchi A, et al. A strategy using photodynamic therapy and clofibric acid to treat peritoneal dissemination ofovarian cancer. Asian Pac J Cancer Prev. 2016;17:775\u20139.10.7314\/APJCP.2016.17.2.775","DOI":"10.7314\/APJCP.2016.17.2.775"},{"key":"2025120909201197956_j_pp-2018-0124_ref_047_w2aab3b7b3b1b6b1ab1b7c47Aa","doi-asserted-by":"crossref","unstructured":"Sindelar WF, DeLaney TF, Tochner Z, Thomas GF, Dachoswki LJ, Smith PD, et al. Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I Study Arch Surg. 1991;126:318\u201324.","DOI":"10.1001\/archsurg.1991.01410270062011"},{"key":"2025120909201197956_j_pp-2018-0124_ref_048_w2aab3b7b3b1b6b1ab1b7c48Aa","doi-asserted-by":"crossref","unstructured":"DeLaney TF, Sindelar WF, Tochner Z, Smith PD, Friauf WS, Thomas G, et al. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int J Radiat Oncol Biol Phys. 1993;25:445\u201357.843652310.1016\/0360-3016(93)90066-5","DOI":"10.1016\/0360-3016(93)90066-5"},{"key":"2025120909201197956_j_pp-2018-0124_ref_049_w2aab3b7b3b1b6b1ab1b7c49Aa","doi-asserted-by":"crossref","unstructured":"Wierrani F, Fiedler D, Grin W, Henry M, Dienes E, Gharehbaghi K, et al. Clinical effect of meso-tetrahydroxyphenylchlorine based photodynamic therapy in recurrent carcinoma of the ovary: preliminary results. Br J Obstet Gynaecol. 1997;104:376\u20138.10.1111\/j.1471-0528.1997.tb11472.x9091020","DOI":"10.1111\/j.1471-0528.1997.tb11472.x"},{"key":"2025120909201197956_j_pp-2018-0124_ref_050_w2aab3b7b3b1b6b1ab1b7c50Aa","doi-asserted-by":"crossref","unstructured":"Bauer TW, Hahn SM, Spitz FR, Kachur A, Glatstein E, Fraker DL. Preliminary report of photodynamic therapy for intraperitoneal sarcomatosis. Ann Surg Oncol. 2001;8:254\u20139.1131494310.1007\/s10434-001-0254-7","DOI":"10.1007\/s10434-001-0254-7"},{"key":"2025120909201197956_j_pp-2018-0124_ref_051_w2aab3b7b3b1b6b1ab1b7c51Aa","doi-asserted-by":"crossref","unstructured":"Canter RJ, Mick R, Kesmodel SB, Raz DJ, Spitz FR, Metz JM, et al. Intraperitoneal photodynamic therapy causes a capillary-leak syndrome. Ann Surg Oncol. 2003;10:514\u201324.10.1245\/ASO.2003.11.00512794017","DOI":"10.1245\/ASO.2003.11.005"},{"key":"2025120909201197956_j_pp-2018-0124_ref_052_w2aab3b7b3b1b6b1ab1b7c52Aa","doi-asserted-by":"crossref","unstructured":"Hendren SK, Hahn SM, Spitz FR, Bauer TW, Rubin SC, Zhu T, et al. Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Ann Surg Oncol. 2001;8:65\u201371.1120622710.1007\/s10434-001-0065-x","DOI":"10.1007\/s10434-001-0065-x"},{"key":"2025120909201197956_j_pp-2018-0124_ref_053_w2aab3b7b3b1b6b1ab1b7c53Aa","doi-asserted-by":"crossref","unstructured":"Wilson JJ, Jones H, Burock M, Smith D, Fraker DL, Metz J, et al. Patterns of recurrence in patients treated with photodynamic therapy for intraperitoneal carcinomatosis and sarcomatosis. Int J Oncol. 2004;24:711\u20137.14767557","DOI":"10.3892\/ijo.24.3.711"},{"key":"2025120909201197956_j_pp-2018-0124_ref_054_w2aab3b7b3b1b6b1ab1b7c54Aa","doi-asserted-by":"crossref","unstructured":"Hahn SM, Fraker DL, Mick R, Metz J, Busch TM, Smith D, et al.A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis. Clin Cancer Res. 2006;12:2517\u201325.1663886110.1158\/1078-0432.CCR-05-1625","DOI":"10.1158\/1078-0432.CCR-05-1625"},{"key":"2025120909201197956_j_pp-2018-0124_ref_055_w2aab3b7b3b1b6b1ab1b7c55Aa","doi-asserted-by":"crossref","unstructured":"Levi-Polyachenko NH, Merkel EJ, Jones BT, Carroll DL, Stewart JH, IV. Rapid photothermal intracellular drug delivery using multiwalled carbon nanotubes. Mol Pharm. 2009;6:1092\u20139.10.1021\/mp800250e19545174","DOI":"10.1021\/mp800250e"},{"key":"2025120909201197956_j_pp-2018-0124_ref_056_w2aab3b7b3b1b6b1ab1b7c56Aa","doi-asserted-by":"crossref","unstructured":"Takagi A, Hirose A, Nishimura T, Fukumori N, Ogata A, Ohashi N, et al. Induction of mesothelioma in p53+\/- mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci. 2008;33:105\u201316.10.2131\/jts.33.105","DOI":"10.2131\/jts.33.105"},{"key":"2025120909201197956_j_pp-2018-0124_ref_057_w2aab3b7b3b1b6b1ab1b7c57Aa","doi-asserted-by":"crossref","unstructured":"Rittinghausen S, Hackbarth A, Creutzenberg O, Ernst H, Heinrich U, Leonhardt A, et al. The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats. Part Fibre Toxicol. 2014;11:59.2541047910.1186\/s12989-014-0059-z","DOI":"10.1186\/s12989-014-0059-z"},{"key":"2025120909201197956_j_pp-2018-0124_ref_058_w2aab3b7b3b1b6b1ab1b7c58Aa","doi-asserted-by":"crossref","unstructured":"Muller J, Delos M, Panin N, Rabolli V, Huaux F, Lison D. Absence of carcinogenic response to multiwall carbon nanotubes in a 2 year bioassay in the peritoneal cavity of the rat. Toxicol Sci. 2009;110:442\u20138.10.1093\/toxsci\/kfp100","DOI":"10.1093\/toxsci\/kfp100"},{"key":"2025120909201197956_j_pp-2018-0124_ref_059_w2aab3b7b3b1b6b1ab1b7c59Aa","doi-asserted-by":"crossref","unstructured":"Zhang XD, Wu HY, Wu D, Wang YY, Chang JH, Zhai ZB, et al. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int J Nanomedicine. 2010;5:771\u201381.21042423","DOI":"10.2147\/IJN.S8428"},{"key":"2025120909201197956_j_pp-2018-0124_ref_060_w2aab3b7b3b1b6b1ab1b7c60Aa","doi-asserted-by":"crossref","unstructured":"Bagley AF, Hill S, Rogers GS, Bhatia SN. Plasmonic photothermal heating of intraperitoneal tumors through the use of an implanted near-infrared source. ACS Nano. 2013;7:8089\u201397.10.1021\/nn403375723961973","DOI":"10.1021\/nn4033757"},{"key":"2025120909201197956_j_pp-2018-0124_ref_061_w2aab3b7b3b1b6b1ab1b7c61Aa","doi-asserted-by":"crossref","unstructured":"Diddens-Tschoeke HC, H\u00fcttmann G, Gruber AD, Pottier RH, Hanken H. Localized thermal tumor destruction using dye-enhanced photothermal tumor therapy. Lasers Surg Med. 2015;47:452\u201361.2605293110.1002\/lsm.22356","DOI":"10.1002\/lsm.22356"},{"key":"2025120909201197956_j_pp-2018-0124_ref_062_w2aab3b7b3b1b6b1ab1b7c62Aa","doi-asserted-by":"crossref","unstructured":"Wu CC, Yang YC, Hsu YT, Wu TC, Hung CF, Huang JT, et al. Nanoparticle-induced intraperitoneal hyperthermia and targeted photoablation in treating ovarian cancer. Oncotarget. 2015;6:26861\u201375.26318039","DOI":"10.18632\/oncotarget.4766"},{"key":"2025120909201197956_j_pp-2018-0124_ref_063_w2aab3b7b3b1b6b1ab1b7c63Aa","doi-asserted-by":"crossref","unstructured":"Nowacki M, Wisniewski M, Werengowska-Ciecwierz K, Roszek K, Czarnecka J, \u0141akomska I, et al. Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis. Oncotarget. 2015;6:22776\u201398.26254295","DOI":"10.18632\/oncotarget.4309"},{"key":"2025120909201197956_j_pp-2018-0124_ref_064_w2aab3b7b3b1b6b1ab1b7c64Aa","doi-asserted-by":"crossref","unstructured":"Zhang Y, Liu Z, Thackray BD, Bao Z, Yin X, Shi F, et al. Intraoperative Raman-guided chemo-photothermal synergistic therapy of advanced disseminated ovarian cancers. Small. 2018;e1801022 (doi:10.1002\/smll201801022).29974621","DOI":"10.1002\/smll.201801022"},{"key":"2025120909201197956_j_pp-2018-0124_ref_065_w2aab3b7b3b1b6b1ab1b7c65Aa","doi-asserted-by":"crossref","unstructured":"Duncan R, Sat-Klopsch YN, Burger AM, Bibby MC, Fiebig HH, Sausville EA. Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rate. Cancer Chemother Pharmacol. 2013;72:417\u201327.2379768610.1007\/s00280-013-2209-7","DOI":"10.1007\/s00280-013-2209-7"},{"key":"2025120909201197956_j_pp-2018-0124_ref_066_w2aab3b7b3b1b6b1ab1b7c66Aa","doi-asserted-by":"crossref","unstructured":"Maeda H. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. J Control Release. 2012;164:138\u201344.2259514610.1016\/j.jconrel.2012.04.038","DOI":"10.1016\/j.jconrel.2012.04.038"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/pp\/3\/4\/article-20180124.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2018-0124\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2018-0124\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T15:42:17Z","timestamp":1775317337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2018-0124\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":66,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,10,20]]},"published-print":{"date-parts":[[2018,12,19]]}},"alternative-id":["10.1515\/pp-2018-0124"],"URL":"https:\/\/doi.org\/10.1515\/pp-2018-0124","relation":{},"ISSN":["2364-768X","2364-7671"],"issn-type":[{"value":"2364-768X","type":"electronic"},{"value":"2364-7671","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,1]]},"article-number":"20180124"}}